Quick Answer
Hims & Hers Health, Inc. reported Operating Income Loss of $105.61 million for the year ending 2025.
- Hims & Hers Health, Inc. showed an increase of +70.6% in Operating Income Loss from 2024 to 2025.
- This data is from Hims & Hers Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 23, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2019: -$16.6 thousand | Q3 2019: -$449.9 thousand | Q1 2020: -$6.22 million | Q2 2020: -$979.0 thousand | Q3 2020: -$3.32 million | Q1 2021: -$48.41 million | Q2 2021: -$17.41 million | Q3 2021: -$27.66 million | Q1 2022: -$16.92 million | Q2 2022: -$20.19 million | Q3 2022: -$19.98 million | Q1 2023: -$11.26 million | Q2 2023: -$9.24 million | Q3 2023: -$8.55 million | Q1 2024: $9.90 million | Q2 2024: $11.03 million | Q3 2024: $22.37 million | Q1 2025: $57.90 million | Q2 2025: $26.72 million | Q3 2025: $11.81 million.
- Over the full 7 years of available data (2019 to 2025), Hims & Hers Health, Inc.'s Operating Income Loss has grown by 241.9%.
- Historical annual values: Fiscal year 2025: $105.61 million | Fiscal year 2024: $61.90 million | Fiscal year 2023: -$29.45 million | Fiscal year 2022: -$68.70 million | Fiscal year 2021: -$115.04 million | Fiscal year 2020: -$15.14 million | Fiscal year 2019: -$74.41 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: